Literature DB >> 14558735

Frequency and antibiotic susceptibility pattern of mycobacterial isolates from extra-pulmonary tuberculosis cases.

T Butt1, S Y Kazmi, R N Ahmad, A Mahmood, K A Karamat, M Anwar.   

Abstract

OBJECTIVE: To determine the frequency and antimicrobial susceptibility pattern of extra-pulmonary tuberculosis in Rawalpindi.
SETTING: Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi.
METHODS: Between September 2000 and August 2002, 899 pulmonary and 460 extra-pulmonary specimens from suspected cases of tuberculosis were examined. The radiometric BACTEC 460 TB system was used for culture and antimicrobial susceptibility testing.
RESULTS: Mycobacteria were isolated from 291 pulmonary specimens and 98 extra-pulmonary specimens. The frequency of extra-pulmonary tuberculosis was 25.2%. The commonest source of isolation was pus (44.9%, frequency 11.3%), followed by lymph nodes (13.3%, frequency 3.3%) and pleural fluid (13.3%, frequency 3.3%). We tested the anti-microbial susceptibility of the isolates to the four first line anti-tuberculous drugs, rifampicin, isoniazid, streptomycin and ethambutol. Of the extra-pulmonary isolates 13.3% were resistant to a single drug, 21.4% were multi-drug resistant and 9.2% were resistant to all the four drugs.
CONCLUSION: Increased awareness of the magnitude of the problem posed by extra-pulmonary tuberculosis is required so that appropriate control measures can be adopted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14558735

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  Drug resistant strains of Mycobacterium tuberculosis identified through PCR-RFLP from patients of Central Punjab, Pakistan.

Authors:  Muhammad Riaz; Zahed Mahmood; Muhammad Tariq Javed; Irum Javed; Muhammad Shahid; Mazhar Abbas; Syed Ehtisham-Ul-Haque
Journal:  Int J Immunopathol Pharmacol       Date:  2016-04-11       Impact factor: 3.219

2.  Rifampin resistance among individuals with extrapulmonary tuberculosis: 4 years of experience from a reference laboratory.

Authors:  S Baghbanbashi; S Mohammad J Mousavi; H Dabiri; M Hakemi-Vala; H Goudarzi; G Hamzehloo; S Amini; M J Nasiri
Journal:  New Microbes New Infect       Date:  2021-01-20

3.  Clinical, molecular and drug sensitivity pattern of mycobacterial isolates from extra-pulmonary tuberculosis cases in Addis Ababa, Ethiopia.

Authors:  Workneh Korma; Adane Mihret; Jemal Hussien; Richard Anthony; Mekuria Lakew; Abraham Aseffa
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.